MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/04/6603-368-376$20.00
Mol Pharmacol 66:368-376, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Im, J.-Y.
Right arrow Articles by Han, P.-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Im, J.-Y.
Right arrow Articles by Han, P.-L.

COX-2 Regulates the Insulin-Like Growth Factor I–Induced Potentiation of Zn2+-Toxicity in Primary Cortical Culture

Joo-Young Im, Doyeun Kim1, Kang-Woo Lee, Jung-Bin Kim, Ja-Kyeong Lee, Dong Sik Kim, Young Ik Lee, Kwon-Soo Ha, Cheol O Joe, and Pyung-Lim Han

Department of Neuroscience, Neuroscience Research Center and Medical Research Institute, Ewha Womans University School of Medicine, Seoul, 110-783, Korea (J.-Y.I., D.K., K.-W.L., P.-L.H.); Department of Biological Sciences, Korea Advanced Institute of Science Technology, Daejon, 305-701, Korea (D.K., C.O.J.); Department of Anatomy, Inha University School of Medicine, Inchon, 400-712, Korea (J.-B.K., J.-K.L.); Liver Cell Signal Transduction Lab., Bioscience Research Division, Korea Research Institute of Bioscience and Biotechnology, Daejeon, 305-333, Korea (D.S.K., Y.I.L.); Department of Molecular and Cellular Biochemistry, Kangwon National University School of medicine, Chunchon, 200-701, Korea (K.-S.H.)

The pretreatment of cultured cortical neurons with neurotrophic factors markedly potentiates the cytotoxicity induced by low concentrations of Zn2+ or excitotoxins. In the current study, we investigated the mechanism underlying the insulin-like growth factor-I (IGF-I)-induced Zn2+ toxicity potentiation. The pretreatment of primary cortical cultures for more than 12 h with 100 ng/ml of IGF-I increased the cytotoxicity induced by 80 µM Zn2+ by more than 2-fold. The IGF-I–enhanced cell death was blocked by the COX-2–specific inhibitors N-[2-(cyclohexyloxyl)-4-nitrophenyl]-methane sulfonamide (NS-398; 10–100 µM) and 1-[(4-methylsulfonyl)phenyl]-3-trifluoro-methyl-5-[(4-fluoro)phenyl]pyrazole (SC58125; 10 µM) and by the antioxidant trolox (30 µM). In addition, it was observed that COX-2 expression was increased 12 to 24 h after IGF-I treatment. Preincubation of cortical cultures with IGF-I increased arachidonic acid (AA)-induced cytotoxicity, and AA increased Zn2+ toxicity, which suggested the involvement of COX activity in these cellular responses. Moreover, enhanced COX-2 activity led to a decrease in the cell's reducing power, as indicated by a gradual depletion of intracellular GSH. Cortical neurons pretreated with IGF-I and then Zn2+ showed consistently enhanced reactive oxygen species production, which was repressed by NS-398 and SC58125. Cortical neurons treated with Zn2+ and then AA displayed the increased ROS production, which was also suppressed by NS-398 and SC58125. These results suggest that COX-2 is an endogenous factor responsible for the IGF-I–induced potentiation of Zn2+ toxicity and that enhanced COX-2 activity leads to a decrease in the cell's reducing power and an increase in ROS accumulation in primary cortical cultures.


Received December 15, 2003; accepted May 13, 2004

Address correspondence to: Dr. Pyung-Lim Han, Ewha Institute of Neuroscience, Ewha Womans University School of Medicine, 70 Jongno-6-Ga, Jongno-Gu, Seoul, 110-783, Republic of Korea. E-mail: plhan{at}ewha.ac.kr







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics